Home World News FDA Approves Nivolumab with Chemotherapy for Previously Untreated Hodgkin Lymphoma World News FDA Approves Nivolumab with Chemotherapy for Previously Untreated Hodgkin Lymphoma By Ogkologos - April 1, 2026 257 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the Study CA209-8UT (SWOG 1826) Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR EMA Recommends Extension of Indications for Blinatumomab June 9, 2021 Քաղցկեղն իմ համայնքում՝ Քաղցկեղով երեխաների բուժումը Հայաստանում May 13, 2021 EMA Recommends Granting a Marketing Authorisation for Acalabrutinib July 30, 2020 FDA Approves Ivosidenib in Combination with Azacitidine for Newly Diagnosed AML June 13, 2022 Load more HOT NEWS October is National Dental Hygiene Month ‘Levelling Up’: What should it mean for cancer? Inavolisib Plus Palbociclib–Fulvestrant Prolongs PFS in Patients with PIK3CA-mutated, HR-positive, HER2-negative... Anticancer Drugs in the Adjuvant Setting Have Considerable Costs Per Event...
